Biotech · Private company
Acacia Pharma Ltd
Track this companyFree. Adds Acacia Pharma Ltd to your Dealase workspace and tells you when its record changes.
Clinical trials81 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- Amisulpride InjectionPhase 3 · Nausea and Vomiting, PostoperativeClinicalTrials.gov · fetched Nov 12, 2026
- APD421Phase 3 · PONVClinicalTrials.gov · fetched Nov 12, 2026
- APD421Phase 3 · Postoperative Nausea and VomitingClinicalTrials.gov · fetched Nov 12, 2026
- APD421- Amisulpride for IV injectionPhase 3 · PONVClinicalTrials.gov · fetched Nov 12, 2026
- DexamethasonePhase 3 · Nausea and Vomiting, PostoperativeClinicalTrials.gov · fetched Nov 12, 2026
- RemimazolamPhase 3 · Pediatric ALLClinicalTrials.gov · fetched Nov 12, 2026
- Amisulpride IVPhase 1 · Renal Disease, End StageClinicalTrials.gov · fetched Nov 12, 2026
- Amisulpride Oral TabletPhase 1 · Renal Disease, End StageClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric PatientsPHASE2_PHASE3 · COMPLETED · started Jan 18, 2024ClinicalTrials.gov NCT05546359 · fetched Nov 12, 2026
- Investigation of Remimazolam in Children Undergoing Sedation for Medical ProceduresPHASE2_PHASE3 · ACTIVE_NOT_RECRUITING · started Nov 15, 2021ClinicalTrials.gov NCT04851717 · fetched Nov 12, 2026
- PK Study of IV and Oral Amisulpride in Subjects With Severe Renal ImpairmentPHASE1 · COMPLETED · started Jun 3, 2021ClinicalTrials.gov NCT04849650 · fetched Nov 12, 2026
- Study of APD421 as PONV Treatment (Prior Prophylaxis)PHASE3 · COMPLETED · started Mar 1, 2016ClinicalTrials.gov NCT02646566 · fetched Nov 12, 2026
- Study of APD421 as PONV Treatment (no Prior Prophylaxis)PHASE3 · COMPLETED · started Sep 1, 2015ClinicalTrials.gov NCT02449291 · fetched Nov 12, 2026
- Phase IIIb Study of APD421 in Combination as PONV ProphylaxisPHASE3 · COMPLETED · started Feb 1, 2015ClinicalTrials.gov NCT02337062 · fetched Nov 12, 2026
- US Phase III Study of APD421 in PONVPHASE3 · COMPLETED · started Aug 1, 2013ClinicalTrials.gov NCT01991860 · fetched Nov 12, 2026
- Phase II Dose-ranging Study of APD421 in PONVPHASE2 · COMPLETED · started Jan 1, 2012ClinicalTrials.gov NCT01510704 · fetched Nov 12, 2026